Attorneys Brady Bizarro and Andrew Silverio discuss the recent senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.

Click here to check out the podcast! (Make sure you subscribe to our YouTube and Apple Podcasts Channels!)